Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma

Leuk Lymphoma. 2014 Mar;55(3):683-4. doi: 10.3109/10428194.2013.797975. Epub 2013 Jul 25.

Authors

Armin Rashidi¹, Louise Man, John R Howard, Daniel Atienza, Stephen I Fisher

Affiliation

¹ Department of Internal Medicine, Eastern Virginia Medical School , Norfolk, VA.

PMID: 23837492
DOI: 10.3109/10428194.2013.797975

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antimetabolites, Antineoplastic / adverse effects
Antimetabolites, Antineoplastic / therapeutic use*
Bone Marrow / pathology
Capecitabine
Deoxycytidine / adverse effects
Deoxycytidine / analogs & derivatives*
Deoxycytidine / therapeutic use
Fluorouracil / adverse effects
Fluorouracil / analogs & derivatives*
Fluorouracil / therapeutic use
Humans
Leukemia, Promyelocytic, Acute / diagnosis
Leukemia, Promyelocytic, Acute / etiology*
Male
Middle Aged
Neoplasms, Second Primary / diagnosis
Neoplasms, Second Primary / etiology*
Rectal Neoplasms / drug therapy*
Rectal Neoplasms / radiotherapy
Rectal Neoplasms / surgery

Substances

Antimetabolites, Antineoplastic
Deoxycytidine
Capecitabine
Fluorouracil